Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia.

Ferrari, Roberto; Aguiar, Carlos; Alegria, Eduardo; Bonadonna, Riccardo C; Cosentino, Francesco; Elisaf, Moses; Farnier, Michel; Ferrières, Jean; Filardi, Pasquale Perrone; Hancu, Nicolae; Kayikcioglu, Meral; Mello E Silva, Alberto; Millan, Jesus; Reiner, Željko; Tokgozoglu, Lale; Valensi, Paul; Viigimaa, Margus; Vrablik, Michal; Zambon, Alberto; Zamorano, José Luis ... Catapano, Alberico L (2017). Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia. European heart journal supplements : journal of the European Society of Cardiology, 18 (Suppl C), C2−C12.10.1093/eurheartj/suw009.
ajakirjaartikkel
Ferrari, Roberto; Aguiar, Carlos; Alegria, Eduardo; Bonadonna, Riccardo C; Cosentino, Francesco; Elisaf, Moses; Farnier, Michel; Ferrières, Jean; Filardi, Pasquale Perrone; Hancu, Nicolae; Kayikcioglu, Meral; Mello E Silva, Alberto; Millan, Jesus; Reiner, Željko; Tokgozoglu, Lale; Valensi, Paul; Viigimaa, Margus; Vrablik, Michal; Zambon, Alberto; Zamorano, José Luis; Catapano, Alberico L
  • Inglise
European heart journal supplements : journal of the European Society of Cardiology
1520-765X
18
Suppl C
2017
C2C12
Ilmunud
1.1. Teadusartiklid, mis on kajastatud Web of Science andmebaasides Science Citation Index Expanded, Social Sciences Citation Index, Arts & Humanities Citation Index ja/või andmebaasis Scopus (v.a. kogumikud)
WOS

Viited terviktekstile

dx.doi.org/10.1093/eurheartj/suw009

Lisainfo

Atherogenic dyslipidaemia;Cardiovascular risk;Fenofibrate;Fenofibrate–statin combination therapy;Residual cardiovascular risk;Statin